CVE-2026-1243: IBM Content Navigator 3.0.15, 3.1.0, and 3.2.0 is vulnerable to cross-site scripting
CVE-2026-1243 is a medium-severity flaw (CVSS 5.4) affecting content navigator. Below: why it ranks where it does, which versions are affected, what to do, and the exact commands.
IBM Content Navigator 3.0.15, 3.1.0, and 3.2.0 is vulnerable to cross-site scripting. This vulnerability allows an authenticated user to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session.
Why this priority
- No elevated risk signals yet
No fix is published yet: follow the downgrade or mitigation steps.
Risk facts
| CVSS score | 5.4 (Medium) |
| Attack vector | Network (remote) |
| Attack complexity | Low |
| Privileges needed | Low |
| User interaction | Required |
| EPSS exploit chance | 0.2% (top 89%) |
| CISA exploited list | No |
| Weakness | CWE-79 |
| Published | 2026-04-02 |
| Last modified | 2026-10-26 |
Last updated 2026-10-26 · Sources: CVE Program, NVD, CISA KEV, EPSS and vendor advisories · How we score
Am I affected?
Timeline
- Published CVE record published
- Updated Record last modified
Scores and fixes here are computed automatically from those and other public sources. Confirm with the vendor advisory before changing production systems.
Quick answers
How do I fix CVE-2026-1243?
content navigator: downgrade or apply the listed mitigation. Exact commands for each OS are on this page.
Is CVE-2026-1243 being exploited?
CVE-2026-1243 is not on the CISA Known Exploited Vulnerabilities list at the time of the last update. Check again, as this can change.
What does CVE-2026-1243 affect?
CVE-2026-1243 affects content navigator. Severity is medium (CVSS 5.4). IBM Content Navigator 3.0.15, 3.1.0, and 3.2.0 is vulnerable to cross-site scripting. This vulnerability allows an authenticated user to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially lead
How urgent is CVE-2026-1243?
Priority 22/100. No elevated risk signals yet.